Immunological Prevention of Hydatid Disease and Cysticercosis

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project seeks to develop practical vaccines to control the transmission of cysticercosis and hydatid disease. These diseases are caused by infection with the larval stages of tapeworm parasites which have a worldwide distribution and cause substantial human morbidity and mortality. The parasites are transmitted to humans from animals. Methods for control of transmission of infection currently rely on public education and anthelmintic treatment of animals. These measures are often ineffective and there is an urgent need for new tools to help control transmission of these important diseases. Previous research has shown that the animal hosts of these parasites can be protected from infection by vaccination. Prevention of infection in the parasites' animal hosts has the effect of breaking the parasite life cycle and indirectly removes the source of infection for humans. This project will further develop an existing vaccine against hydatid disease, will develop a new vaccine against cysticercosis and will participate in initial international parasite control campaigns based on application of these vaccines.

Funded Activity Details

Start Date: 01-01-2001

End Date: 01-01-2005

Funding Scheme: NHMRC Project Grants

Funding Amount: $345,340.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Humoural immunology and immunochemistry

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Cysticercosis | Disease prevention | Hydatid disease | Immunity | Parasite | Parasite infection | Vaccination | Zoonotic disease